Posttraumatic administration of a sub-anesthetic dose of ketamine exerts neuroprotection via attenuating inflammation and autophagy

Neuroscience

Volumn 343, Issue , 2017, Pages 30-38

  Wang, C Q ^a,b   Ye, Y ^a   Chen, F ^a   Han, W C ^b   Sun, J M ^b   Lu, X ^a   Guo, R ^a   Cao, K ^b   Zheng, M J ^b   Liao, L C ^a  

^a SICHUAN UNIVERSITY   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

autophagy; ketamine; mTOR; traumatic brain injury

Indexed keywords

ADENOSINE TRIPHOSPHATE; BECLIN 1; INTERLEUKIN 6; KETAMINE; MAMMALIAN TARGET OF RAPAMYCIN; TUMOR NECROSIS FACTOR; ANTIINFLAMMATORY AGENT; MTOR PROTEIN, RAT; NEUROPROTECTIVE AGENT; TARGET OF RAPAMYCIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOPHAGY; BEHAVIOR; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITE; DENDRITIC SPINE; DOWN REGULATION; MALE; MEMORY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; SIGNAL TRANSDUCTION; SPATIAL LEARNING; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN; BRAIN INJURIES, TRAUMATIC; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; MAZE TEST; METABOLISM; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGY; RANDOMIZATION; SPATIAL MEMORY; SPRAGUE DAWLEY RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTI-INFLAMMATORY AGENTS; AUTOPHAGY; BRAIN; BRAIN INJURIES, TRAUMATIC; DENDRITES; DISEASE MODELS, ANIMAL; INTERLEUKIN-6; KETAMINE; MALE; MAZE LEARNING; NEUROPROTECTION; NEUROPROTECTIVE AGENTS; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; SPATIAL MEMORY; TOR SERINE-THREONINE KINASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85007590914     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2016.11.029     Document Type: Article

References (46)

1. Adams, S.D., Radhakrishnan, R.S., Helmer, K.S., Mercer, D.W., Effects of anesthesia on lipopolysaccharide-induced changes in serum cytokines. J Trauma 65 (2008), 170–174.
2. Amini, M., Ma, C.L., Farazifard, R., Zhu, G.Q., Zhang, Y., Vanderluit, J., Zoltewicz, J.S., Hage, F., Savitt, J.M., Lagace, D.C., Slack, R.S., Beique, J.C., Baudry, M., Greer, P.A., Bergeron, R., Park, D.S., Conditional disruption of calpain in the CNS alters dendrite morphology, impairs LTP, and promotes neuronal survival following injury. J Neurosci 33 (2013), 5773–5784.
3. Belanger, H.G., Vanderploeg, R.D., The neuropsychological impact of sports-related concussion: a meta-analysis. J Int Neuropsychol Soc 11 (2005), 345–357.
4. Bhutta, A.T., Schmitz, M.L., Swearingen, C., James, L.P., Wardbegnoche, W.L., Lindquist, D.M., Glasier, C.M., Tuzcu, V., Prodhan, P., Dyamenahalli, U., Imamura, M., Jaquiss, R.D.B., Anand, K.J.S., Ketamine as a neuroprotective and anti-inflammatory agent in children undergoing surgery on cardiopulmonary bypass: a pilot randomized, double-blind, placebo-controlled trial. Pediatr Crit Care Med 13 (2012), 328–337.
5. Bigford, G.E., Alonso, O.F., Dietrich, D., Keane, R.W., A novel protein complex in membrane rafts linking the NR2B glutamate receptor and autophagy is disrupted following traumatic brain injury. J Neurotrauma 26 (2009), 703–720.
6. Chang, M.L., Yang, J., Kem, S., Klaidman, L., Sugawara, T., Chan, P.H., Adams, J.D., Nicotinamide and ketamine reduce infarct volume and DNA fragmentation in rats after brain ischemia and reperfusion. Neurosci Lett 322 (2002), 137–140.
7. Chang, Y., Lee, J.J., Hsieh, C.Y., Hsiao, G., Chou, D.S., Sheu, J.R., Inhibitory effects of ketamine on lipopolysaccharide-induced microglial activation. Mediators Inflamm., 2009, 2009, 705379.
8. DeClue, A.E., Cohn, L.A., Lechner, E.S., Bryan, M.E., Dodam, J.R., Effects of subanesthetic doses of ketamine on hemodynamic and immunologic variables in dogs with experimentally induced endotoxemia. Am J Vet Res 69 (2008), 228–232.
9. Diskin, T., Tal-Or, P., Erlich, S., Mizrachy, L., Alexandrovich, A., Shohami, E., Pinkas-Kramarski, R., Closed head injury induces upregulation of Beclin 1 at the cortical site of injury. J Neurotrauma 22:7 (2005), 750–762.
10. DoD Worldwide Numbers for TBI (2016) Available at: http://www.dvbic.org/dod-worldwide-numbers-tbi. This site's content was last updated on: April 7, 2016.
11. Duman, R.S., Aghajanian, G.K., Synaptic dysfunction in depression: potential therapeutic targets. Science 338:6103 (2012), 68–72.
12. Erlich, S., Alexandrovich, A., Shohami, E., Pinkas-Kramarski, R., Rapamycin is a neuroprotective treatment for traumatic brain injury. Neurobiol Dis 26 (2007), 86–93.
13. Fletcher, P.C., Honey, G.D., Schizophrenia, ketamine and cannabis: evidence of overlapping memory deficits. Trends Cogn Sci 10 (2006), 167–174.
14. Global Health Observatory (GHO) data (2016) Available at: http://gamapserver.who.int/gho/interactive_charts/road_safety/road_traffic_deaths2/atlas.html.
15. Guo, D., Zeng, L., Brody, D.L., Wong, M., Rapamycin attenuates the development of posttraumatic epilepsy in a mouse model of traumatic brain injury. PLoS One, 8, 2013, e64078.
16. Harish, G., Mahadevan, A., Pruthi, N., Sreenivasamurthy, S.K., Puttamallesh, V.N., Keshava Prasad, T.S., Shankar, S.K., Srinivas Bharath, M.M., Characterization of traumatic brain injury in human brains reveals distinct cellular and molecular changes in contusion and pericontusion. J Neurochem 134:1 (2015), 156–172.
17. Himmelseher, S., Pfenninger, E., Georgieff, M., The effects of ketamine-isomers on neuronal injury and regeneration in rat hippocampal neurons. Anesth Analg 83 (1996), 505–512.
18. Himmelseher, S., Pfenninger, E., Kochs, E., Auchter, M., S(+)-ketamine up-regulates neuronal regeneration associated proteins following glutamate injury in cultured rat hippocampal neurons. J Neurosurg Anesth 12 (2000), 84–94.
19. Jones, P.A., Andrews, P.J., Midgley, S., Anderson, S.I., Piper, I.R., Tocher, J.L., Housley, A.M., Corrie, J.A., Slattery, J., Dearden, N.M., et al. Measuring the burden of secondary insults in head-injured patients during intensive care. J Neurosurg Anesthesiol 6 (1994), 4–14.
20. Kanno, H., Ozawa, H., Sekiguchi, A., Yamaya, S., Itoi, E., Induction of autophagy and autophagic cell death in damaged neural tissue after acute spinal cord injury in mice. Spine 36 (2011), E1427–E1434.
21. Krystal, J.H., Sanacora, G., Duman, R.S., Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond. Biol Psychiatry 73:12 (2013), 1133–1141.
22. Lai, Y., Hickey, R.W., Chen, Y., Bayir, H., Sullivan, M.L., Chu, C.T., Kochanek, P.M., Dixon, C.E., Jenkins, L.W., Graham, S.H., Watkins, S.C., Clark, R.S., Autophagy is increased after traumatic brain injury in mice and is partially inhibited by the antioxidant gamma-glutamylcysteinyl ethyl ester. J Cereb Blood Flow Metab 28 (2008), 540–550.
23. Li, N.X., Lee, B., Liu, R.J., Banasr, M., Dwyer, J.M., Iwata, M., Li, X.Y., Aghajanian, G., Duman, R.S., MTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329 (2010), 959–964.
24. Lipinski, M.M., Wu, J., Faden, A.I., Sarkar, C., Function and mechanisms of autophagy in brain and spinal cord trauma. Antioxid Redox Signal 23:6 (2015), 565–577.
25. Lloyd, E., Somera-Molina, K., Van Eldik, L.J., Watterson, D.M., Wainwright, M.S., Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injury. J Neuroinflammation, 5, 2008, 28.
26. Lodge, D., Mercier, M.S., Ketamine and phencyclidine: the good, the bad and the unexpected. Br J Pharmacol 172:17 (2015), 4254–4276.
27. Lucas, J.H., Wang, G.F., Gross, G.W., NMDA antagonists prevent hypothermic injury and death of mammalian spinal neurons. J. Neurotrauma 7 (1990), 229–236.
28. Lyeth, B.G., Jenkins, L.W., Hamm, R.J., Dixon, C.E., Phillips, L.L., Clifton, G.L., Young, H.F., Hayes, R.L., Prolonged memory impairment in the absence of hippocampal cell death following traumatic brain injury in the rat. Brain Res 526 (1990), 249–258.
29. Meyer, K., Helmick, K., Doncevic, S., Park, R., Severe and penetrating traumatic brain injury in the context of war. J Trauma Nursing 15 (2008), 185–189 quiz 190–181.
30. Morgan, C.J.A., Curran, H.V., Acute and chronic effects of ketamine upon human memory: a review. Psychopharmacology 188 (2006), 408–424.
31. Morris, R.G., Garrud, P., Rawlins, J.N., O'Keefe, J., Place navigation impaired in rats with hippocampal lesions. Nature 297 (1982), 681–683.
32. Rothman, S.M., Thurston, J.H., Hauhart, R.E., Clark, G.D., Solomon, J.S., Ketamine protects hippocampal neurons from anoxia in vitro. Neuroscience 21 (1987), 673–678.
33. Scheff, S.W., Baldwin, S.A., Brown, R.W., Kraemer, P.J., Morris water maze deficits in rats following traumatic brain injury: lateral controlled cortical impact. J Neurotrauma 14 (1997), 615–627.
34. Scheff, S.W., Price, D.A., Schmitt, F.A., Mufson, E.J., Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol Aging 27:10 (2006), 1372–1384.
35. Schmidt, O.I., Heyde, C.E., Ertel, W., Stahel, P.F., Closed head injury–an inflammatory disease?. Brain Res Brain Res Rev 48 (2005), 388–399.
36. Schretlen, D.J., Shapiro, A.M., A quantitative review of the effects of traumatic brain injury on cognitive functioning. Int Rev Psychiatry 15 (2003), 341–349.
37. Selassie, A.W., Zaloshnja, E., Langlois, J.A., Miller, T., Jones, P., Steiner, C., Incidence of long-term disability following traumatic brain injury hospitalization, United States, 2003. J Head Trauma Rehab 23 (2008), 123–131.
38. Semchenko, V.V., Bogolepov, N.N., Stepanov, S.S., Maksimishin, S.V., Khizhnyak, A.S., Synaptic plasticity of the neocortex of white rats with diffuse-focal brain injuries. Neurosci Behav Physiol 36 (2006), 613–618.
39. Silva, L.F., Hoffmann, M.S., Rambo, L.M., Ribeiro, L.R., Lima, F.D., Furian, A.F., Oliveira, M.S., Fighera, M.R., Royes, L.F., The involvement of Na+, K+-ATPase activity and free radical generation in the susceptibility to pentylenetetrazol-induced seizures after experimental traumatic brain injury. J Neurol Sci 308 (2011), 35–40.
40. Silva-Gomez, A.B., Rojas, D., Juarez, I., Flores, G., Decreased dendritic spine density on prefrontal cortical and hippocampal pyramidal neurons in postweaning social isolation rats. Brain Res 983 (2003), 128–136.
41. Tavazzi, B., Signoretti, S., Lazzarino, G., Delfini, R., Cimatti, M., Marmarou, A., Vagnozzi, R., Cerebral oxidative stress and depression of energy metabolism correlate with severity of diffuse brain injury in rats. Neurosurgery 56 (2005), 582–588.
42. Witgen, B.M., Lifshitz, J., Smith, M.L., Schwarzbach, E., Liang, S.L., Grady, M.S., Cohen, A.S., Regional hippocampal alteration associated with cognitive deficit following experimental brain injury: a systems, network and cellular evaluation. Neuroscience 133 (2005), 1–15.
43. Yokobori, S., Mazzeo, A.T., Gajavelli, S., Bullock, M.R., Mitochondrial neuroprotection in traumatic brain injury: rationale and therapeutic strategies. Cns Neurol Disord Drug 13 (2014), 606–619.
44. Zauner, A., Bullock, R., Kuta, A.J., Woodward, J., Young, H.F., Glutamate release and cerebral blood flow after severe human head injury. Acta Neuroch Suppl 67 (1996), 40–44.
45. Zhang, C., Shen, W., Zhang, G., N-methyl-D-aspartate receptor and L-type voltage-gated Ca(2+) channel antagonists suppress the release of cytochrome c and the expression of procaspase-3 in rat hippocampus after global brain ischemia. Neurosci Lett 328 (2002), 265–268.
46. Zhao, Y.D., Ou, S., Cheng, S.Y., Xiao, Z., He, W.J., Zhang, J.H., Ruan, H.Z., Dendritic development of hippocampal CA1 pyramidal cells in a neonatal hypoxia-ischemia injury model. J Neurosci Res 91 (2013), 1165–1173.